SequelSEC

Medline Inc. MDLN

Surgical & Medical Instruments & Apparatus · CIK 0002046386 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$7.68B
Fiscal year ended 2026-06-27
Operating income
$395.00M
Fiscal year ended 2026-06-27
Free cash flow
$604.00M
Fiscal year ended 2026-06-27

Medline Inc. (MDLN) reported revenue of $7.68B for the fiscal year ended 2026-06-27. This page shows 7 annual periods of income statement, balance sheet and cash flow figures normalized from Medline Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

Medline Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-272026-03-282025-12-312025-06-282025-03-292024-12-312023-12-31
Revenue$7.68B$7.35B$14.90B$6.89B$6.64BUnavailableUnavailable
Cost of revenue$5.47B$5.51B$11.11B$4.98B$4.82BUnavailableUnavailable
Gross profit$2.22B$1.84B$3.79B$1.90B$1.82BUnavailableUnavailable
Operating income$395.00M$422.00M$999.00M$642.00M$571.00MUnavailableUnavailable
Net incomeUnavailableUnavailableUnavailable$329.00M$319.00MUnavailableUnavailable
Research & developmentUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 860.89Mshares 824.84MUnavailableUnavailableUnavailableUnavailableUnavailable
Pretax income$235.00M$291.00M$551.00M$359.00M$338.00MUnavailableUnavailable
Income tax expense$96.00M$52.00M$49.00M$26.00M$16.00MUnavailableUnavailable
Diluted EPS$0.07$0.16UnavailableUnavailableUnavailableUnavailableUnavailable
Selling, general & administrative$1.30B$1.23B$2.38B$1.07B$1.07BUnavailableUnavailable
General & administrativeUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Selling & marketingUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable

Balance

Medline Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-272026-03-282025-12-312025-06-282025-03-292024-12-312023-12-31
Cash & equivalents$2.33B$2.24B$1.94BUnavailableUnavailable$199.00MUnavailable
Total assets$39.35B$39.01B$38.48BUnavailableUnavailable$35.98BUnavailable
Current assets$11.74B$11.18B$10.68BUnavailableUnavailable$8.27BUnavailable
Total liabilities$20.27B$19.66B$19.20BUnavailableUnavailable$19.45BUnavailable
Current liabilities$2.71B$2.54B$2.49BUnavailableUnavailable$2.44BUnavailable
Total equity incl. NCI$19.08B$19.35B$19.29BUnavailableUnavailableUnavailableUnavailable
Temporary (mezzanine) equityUnavailableUnavailable$0$367.00M$368.00M$366.00M$233.00M
Inventory$4.66B$4.81B$4.77BUnavailableUnavailable$4.46BUnavailable
Accounts receivable$3.66B$3.67B$3.53BUnavailableUnavailable$3.22BUnavailable
Goodwill$8.07B$8.08B$8.08BUnavailableUnavailable$8.06B$7.53B
Long-term debt$12.55B$12.50B$12.48BUnavailableUnavailable$16.42BUnavailable
Accounts payable$1.04B$932.00M$961.00MUnavailableUnavailable$869.00MUnavailable

Cash flow

Medline Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-272026-03-282025-12-312025-06-282025-03-292024-12-312023-12-31
Operating cash flow$715.00M$412.00M$865.00M$197.00M$682.00MUnavailableUnavailable
Capital expenditures$111.00M$96.00M$239.00M$110.00M$98.00MUnavailableUnavailable
Investing cash flow-$461.00M-$96.00M-$239.00M-$143.00M-$92.00MUnavailableUnavailable
Financing cash flow-$159.00M-$13.00M$736.00M-$328.00M-$9.00MUnavailableUnavailable
Net change in cash$91.00M$296.00M$1.36B-$256.00M$590.00MUnavailableUnavailable
Stock-based compensation$29.00M$23.00M$42.00M$15.00M$19.00MUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
Common share repurchases$0$0$18.00M$6.00M$9.00MUnavailableUnavailable
Depreciation & amortization$256.00M$254.00M$514.00M$250.00M$247.00MUnavailableUnavailable

Derived

Medline Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-272026-03-282025-12-312025-06-282025-03-292024-12-312023-12-31
Free cash flow$604.00M$316.00M$626.00M$87.00M$584.00MUnavailableUnavailable
Gross margin28.8%25.0%25.4%27.7%27.5%UnavailableUnavailable
Operating margin5.1%5.7%6.7%9.3%8.6%UnavailableUnavailable
FCF margin7.9%4.3%4.2%1.3%8.8%UnavailableUnavailable
SBC / revenue0.4%0.3%0.3%0.2%0.3%UnavailableUnavailable
Current ratio4.33x4.41x4.29xUnavailableUnavailable3.39xUnavailable
Revenue YoY growth11.6%10.7%UnavailableUnavailableUnavailableUnavailableUnavailable
Net marginUnavailableUnavailableUnavailable4.8%UnavailableUnavailableUnavailable
R&D / revenueUnavailableUnavailableUnavailableUnavailableUnavailableUnavailableUnavailable
CapEx / revenue1.4%1.3%1.6%1.6%1.5%UnavailableUnavailable
Long-term debt / equity0.66xUnavailable0.65xUnavailableUnavailableUnavailableUnavailable
Effective tax rate40.9%17.9%8.9%7.2%4.7%UnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open MDLN in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-05View SEC filing
10-Q · Filed 2026-05-06View SEC filing
10-K · Filed 2026-02-25View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.